Cellectar Biosciences
CLRB
CLRB
43 hedge funds and large institutions have $14.9M invested in Cellectar Biosciences in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
39% less capital invested
Capital invested by funds: $24.2M → $14.9M (-$9.35M)
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$334K | |
| 2 | +$265K | |
| 3 | +$221K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$214K |
| 5 |
QI
QS Investors
New York
|
+$206K |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$976K | |
| 3 | -$588K | |
| 4 |
Two Sigma Advisers
New York
|
-$425K |
| 5 |
Millennium Management
New York
|
-$397K |